维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Kalow W"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Hypothesis : comparisons of inter- and intra-individual variations can substitute for twin studies in drug research 显示文摘	Kalow W Tang BK Endrenyi L	1998	Pharmacogenetics1998，8，4：	1
2	A method for the detection of atypical forms of human serum cholinesterase,determination of dibucaine numbers显示文摘	Kalow W Genest K	1957	Canadian J Biochem Physiol1957，35，：	1
3	CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine显示文摘	AKLILLU E KALOW W ENDRENYI L	2007	Phar- macogenet Genomics2007，17，11：	1
4	What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects显示文摘	Ozdemir V Shear NH Kalow W	2001	Drug Saf2001，24，2：	1
5	(S) Oxazepam glucuronidation is inhibited by Ketoprofen and other substrates of UGT2B7 显示文摘	PATEL M TANG B K KALOW W	1995	Pharmacogenetics1995，5，1：	1
6	Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method显示文摘	Ozdemir V Kalow W Tang BK	2000	pharmacogenetics2000，10，5：	1
7	Hypothesis: comparisons of inter- and intra- individual variations can substitute for twin studies in drug research显示文摘	Tang BK Endrenyi I	1998	Pharmacogenetics1998，8，：	1
8	Pharmacogenetics:its biological roots and the medical challenge显示文摘		1993	Clin Pharmacol Ther1993，54，3：	1
9	Pharmacogenetics,pharmacogenomics,and pharmacobiology显示文摘	Kalow W		Clin Pharm Ther0，70，1：	1
10	Thiopurine S- methytransferase activity in a Chinese population 显示文摘	Lee EJ Kalow W	1993	Clin Pharmacol Ther1993，54，：	1
11	Metabolic error of muscle metabolism after recovery frome malignant hyperthermia显示文摘	Kalow W Britt BA Terreau ME	1970	Lancet1970，2，：	1
12	What will be the role of pbarmacogenetics in evaluating drug safety and m inimising adverseeffects显示文摘	Shear NH Kalow W	2001	Drug Saf2001，24，2：	1
13	Interthnie factors affecting drag response显示文摘	Kalow W Bertilsson L	1994	Ady Drug Res1994，25，：	1
14	Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method显示文摘	OZDEMIR V KALOW W TANG BK	2000	Pharmacogenetics2000，10，5：	1
15	Treatment-Resistance to Clozapine in Association With Ultrarapid CYP1A2 Activity and the C→A Polymorphism in Intron 1 of the CYP1A2 Gene:Effect of Grapefruit Juice and Low-Dose Fluvoxamine显示文摘	Ozdemir V Kalow W Okey AB	2001	Journal of Clinical Psychopharmacology2001，21，：	1
16	Pharmacogenetics, Pharmacogenomics and pharmacobi- ology 显示文摘	Kalow W	2001	Clin Pharmacol Ther2001，70，1：	1
17	CYPIA2 activity as measured by a caffeine test predicts clozapine and active metab- olite steady-state concentration in patients with schizophrenia 显示文摘	Ozdemir V Kalow W Posner P	2001	Clin Psychopharrnacol2001，21，4：	1
18	Pharmacogenetics,pharmacogenomics and pharmacobiology显示文摘	Kalow W	2001	Clin Pharmacol Ther2001，70，1：	1
19	Intramuscular desferrioxamine in patients with Alzheimer's disease 显示文摘	McLachlan DRC Kruck TPA Kalow W	1991	Lancet1991，337，：	1
20	Pharmacogenetics, pharmacogenomics, and pharma-cobiology显示文摘		2001	Clin Pharmacol Ther2001，70，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示